ZVIA heads into its Q1 2026 print with a consistent insider selling pattern that runs counter to analyst optimism.
The insider story is the sharpest signal in the data. CEO Amy Taylor sold shares across three separate transactions in late March, offloading a combined 144,008 shares at prices between $1.14 and $1.17. CFO Girish Satya sold an additional 41,662 shares on March 25. Chairman Padraic Spence has been selling since at least May 2025, with another 40,000 shares sold in early March. Net insider activity over the past 90 days stands at roughly 226,000 shares sold, worth approximately $273,000. With the stock now trading at $1.19, those sales all came at a premium to the current price.
Short positioning tells a different story — one of retreat rather than pressure. Short interest has fallen sharply, dropping 17.6% over the past week and 34.3% over the past month to 2.73% of free float. Borrow costs are negligible at 0.44%, and availability in the lending market remains loose, with the ORTEX short score easing to 41 from a recent high near 44. The options market reinforces this calm: the put/call ratio has dropped to 0.44, well below its 20-day average of 0.88, suggesting call interest is dominating near-term flow and there is little demand for downside protection ahead of the print.
The bull and bear cases hinge on competing reads of the same distribution story. Bulls point to Zevia's shelf expansion at Costco and Walmart, refreshed packaging, and improving EBITDA margins as evidence the brand is inflecting. Bears flag fragility in that same channel dependency — Costco shipment timing has already caused one earnings miss — alongside broader risks from volatile commodity costs and weak consumer spending. Analyst coverage remains thin and dominated by Telsey Advisory Group, which cut its target from $6 to $5 in February while holding an Outperform rating. Morgan Stanley's Equal-Weight with a $2.70 target sits much closer to reality. The consensus mean of $4.18 is a wide premium to the current $1.19 price, making the targets less a guide to near-term upside and more a reflection of how far the stock has fallen since those ratings were set.
The earnings release will test whether Zevia's distribution gains are translating into durable revenue momentum — or whether the channel-driven volatility that has unsettled prior prints is still the dominant factor in the numbers.
See the live data behind this article on ORTEX.
Open ZVIA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
